The Surge In Cancer And Genetic Disorders Fuels Genotyping Market Expansion: Strategic Insights Driving Genotyping Market Momentum in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Genotyping Market Size By 2025?
The market size for genotyping has seen a swift expansion in the recent past. Its growth will continue to accelerate from $23.04 billion in 2024, reaching $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The significant growth during the historic period can be tied to government endeavors and funding, a sharp reduction in the costs of genotyping, the development of biobanks and genetic databases, a growing occurrence of genetic disorders, and progressive strides in the fields of pharmacogenomics and drug development.

How Big Is the Genotyping Market Size Expected to Grow by 2029?
Anticipated to experience quick expansion in the upcoming years, the genotyping market is projected to rise to $51.43 billion by 2029, with a compound annual growth rate (CAGR) of 17.9%. The predicted increase in this forecast period is primarily due to the augmentation in its utilization for clinical diagnostics, increased demand for personalized medicine, and a surge in research and development initiatives, with broadening applications in agriculture and livestock sectors. Key trends during the forecast period feature a heightened demand for pharmacogenomics, advancements in next-generation sequencing (ngs), an expansion in precision medicine initiatives, a rise in direct-to-consumer (dtc) genetic testing, and an increased emphasis on cancer genomics and personalized treatments.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Which Key Market Drivers Powering Genotyping Market Expansion and Growth?
The anticipated growth of the genotyping market is linked to the increasing rates of cancer and genetic disorders. Cancer encompasses a wide spectrum of diseases that can start in virtually any organ or bodily tissue, whereas genetic disorders stem wholly or partially from a divergence from the typical DNA sequence. Genotyping serves as a diagnostic tool for identifying genetic differences like single nucleotide variations, copy number variations, and substantial changes in DNA structure. By seeking specific gene mutations, genotyping may determine a person's likelihood of developing certain types of cancer. For example, the World Health Organization reported in February 2024 that roughly 20 million new cancer cases had been diagnosed in 2022, leading to 9.7 million fatalities. Additionally, about 53.5 million people were alive five years post their cancer diagnosis. In a similar vein, Gene People UK reported in February 2023 that 1 out of 25 children suffer from a genetic condition, indicating that an annual diagnosis rate of 30,000 babies and children in the UK alone. Beyond that, over 2.4 million children and adults are living with a genetic disorder. Thus, the escalating instances of cancer and genetic disorders are fuelling the expansion of the genotyping market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Genotyping Market?
The enhancement of products through innovation is a prevalent trend in the genotyping market. Companies are employing avant-garde solutions to maintain market dominance. In May 2022, food safety corporation, Neogen, based in the US, collaborated with Gencove Inc., an American sequencing platform for genome exploration, to introduce InfiniSEEK. This pioneering and budget-friendly solution is developed for comprehensive genome sequencing and targeted SNP (single nucleotide polymorphism) examination, marking it a first-of-its-kind for cattle breeders. InfiniSEEK provides the industry with a dependable platform to manage over 400 bovine genetic aspects and events, discover new factors influencing appealing phenotypes, and reduce selection bias by sequencing an entire population or a greater fraction. This exclusive service provides an economical way for consumers to profile cattle globally by merging comprehensive sequencing data, distinct genetic factors, and lineage markers.

What Are the Emerging Segments in the Genotyping Market?
The genotyping market covered in this report is segmented -

1) By Product And Services: Instruments, Reagents And Kits, Bioinformatics, Genotyping Service
2) By Technology: Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction, Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry, Other Technologies
3) By Application: Pharmacogenomics, Diagnostics And Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Other Applications
4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, Other End-Users

Subsegments:
1) By Instruments: Sequencers, PCR Machines, Microarrays, Genotyping Platforms
2) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Next-Generation Sequencing (NGS) Kits
3) By Bioinformatics: Data Analysis Software, Genomic Data Management Tools, Cloud-based Solutions
4) By Genotyping Services: Contract Research Organizations (CRO) Services, Custom Genotyping Services, Sample Preparation Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12059&type=smp

Who Are the Global Leaders in the Genotyping Market?
Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

Which are the Top Profitable Regional Markets for the Genotyping Industry?
North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12059

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.